1793 related articles for article (PubMed ID: 21550068)
21. [Neuromyelitis optica: the disease entity, pathogenesis and therapy].
Fujihara K
Rinsho Shinkeigaku; 2007 Nov; 47(11):883-5. PubMed ID: 18210826
[TBL] [Abstract][Full Text] [Related]
22. [AQP4 immunohistochemistry in neuromyelitis optica and multiple sclerosis: a neuropathological review].
Yoshida M
Brain Nerve; 2010 Sep; 62(9):961-74. PubMed ID: 20844307
[TBL] [Abstract][Full Text] [Related]
23. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
[TBL] [Abstract][Full Text] [Related]
24. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
[TBL] [Abstract][Full Text] [Related]
25. [Differential diagnosis of neuromyelitis optica spectrum disorders].
Tanaka K; Tanaka M
Brain Nerve; 2010 Sep; 62(9):953-60. PubMed ID: 20844306
[TBL] [Abstract][Full Text] [Related]
26. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
27. [Seroprevalence and diagnostic value of aquaporin-4 antibody in patients with inflammatory central nervous system demyelinating diseases].
Wu L; Yang Y; Huang DH; Wu WP
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):350-2. PubMed ID: 21354891
[TBL] [Abstract][Full Text] [Related]
28. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
Fazio R; Malosio ML; Lampasona V; De Feo D; Privitera D; Marnetto F; Centonze D; Ghezzi A; Comi G; Furlan R; Martino G
Mult Scler; 2009 Oct; 15(10):1153-63. PubMed ID: 19667009
[TBL] [Abstract][Full Text] [Related]
29. Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.
Yanagawa K; Kawachi I; Toyoshima Y; Yokoseki A; Arakawa M; Hasegawa A; Ito T; Kojima N; Koike R; Tanaka K; Kosaka T; Tan CF; Kakita A; Okamoto K; Tsujita M; Sakimura K; Takahashi H; Nishizawa M
Neurology; 2009 Nov; 73(20):1628-37. PubMed ID: 19917985
[TBL] [Abstract][Full Text] [Related]
30. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
31. Quantitative measurement of anti-aquaporin-4 antibodies by enzyme-linked immunosorbent assay using purified recombinant human aquaporin-4.
Kim W; Lee JE; Li XF; Kim SH; Han BG; Lee BI; Kim JK; Choi K; Kim HJ
Mult Scler; 2012 May; 18(5):578-86. PubMed ID: 21965418
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica and astrocytic damage in its pathogenesis.
Fujihara K
J Neurol Sci; 2011 Jul; 306(1-2):183-7. PubMed ID: 21396661
[TBL] [Abstract][Full Text] [Related]
33. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.
Hinson SR; Pittock SJ; Lucchinetti CF; Roemer SF; Fryer JP; Kryzer TJ; Lennon VA
Neurology; 2007 Dec; 69(24):2221-31. PubMed ID: 17928579
[TBL] [Abstract][Full Text] [Related]
34. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
[TBL] [Abstract][Full Text] [Related]
35. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
Kinoshita M; Nakatsuji Y; Kimura T; Moriya M; Takata K; Okuno T; Kumanogoh A; Kajiyama K; Yoshikawa H; Sakoda S
Biochem Biophys Res Commun; 2009 Sep; 386(4):623-7. PubMed ID: 19545538
[TBL] [Abstract][Full Text] [Related]
37. [Biomarkers in neuromyelitis optica].
Misu T; Takahashi T; Nakashima I; Fujihara K
Brain Nerve; 2012 May; 64(5):525-35. PubMed ID: 22570066
[TBL] [Abstract][Full Text] [Related]
38. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP
Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders.
Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP
Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532
[TBL] [Abstract][Full Text] [Related]
40. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
